134 related articles for article (PubMed ID: 22972808)
41. The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmes.
Hackshaw A
J Med Screen; 2012; 19 Suppl 1():1-2. PubMed ID: 22972804
[No Abstract] [Full Text] [Related]
42. Modelling the impact of changes in sensitivity on the outcomes of the UK breast screening programme.
Taylor P
J Med Screen; 2010; 17(1):31-6. PubMed ID: 20356943
[TBL] [Abstract][Full Text] [Related]
43. The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.
Broeders MJM; Allgood P; Duffy SW; Hofvind S; Nagtegaal ID; Paci E; Moss SM; Bucchi L
BMC Cancer; 2018 Sep; 18(1):860. PubMed ID: 30176813
[TBL] [Abstract][Full Text] [Related]
44. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates.
Smith RA
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1139-46. PubMed ID: 24991021
[TBL] [Abstract][Full Text] [Related]
45. Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis.
Su SY
Breast Cancer; 2022 Mar; 29(2):336-342. PubMed ID: 34837139
[TBL] [Abstract][Full Text] [Related]
46. Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts.
Ripping TM; Verbeek AL; van der Waal D; Otten JD; den Heeten GJ; Fracheboud J; de Koning HJ; Broeders MJ
Br J Cancer; 2013 Oct; 109(9):2467-71. PubMed ID: 24113141
[TBL] [Abstract][Full Text] [Related]
47. Why is breast-cancer mortality declining?
Jatoi I; Miller AB
Lancet Oncol; 2003 Apr; 4(4):251-4. PubMed ID: 12681269
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.
Autier P; Boniol M; Gavin A; Vatten LJ
BMJ; 2011 Jul; 343():d4411. PubMed ID: 21798968
[TBL] [Abstract][Full Text] [Related]
49. Breast cancer mortality trends in Italy by region and screening programme, 1980-2008.
Gorini G; Zappa M; Cortini B; Martini A; Mantellini P; Ventura L; Carreras G
J Med Screen; 2014 Dec; 21(4):189-93. PubMed ID: 25186117
[TBL] [Abstract][Full Text] [Related]
50. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
Zielonke N; Gini A; Jansen EEL; Anttila A; Segnan N; Ponti A; Veerus P; de Koning HJ; van Ravesteyn NT; Heijnsdijk EAM;
Eur J Cancer; 2020 Mar; 127():191-206. PubMed ID: 31932175
[TBL] [Abstract][Full Text] [Related]
51. The potential of breast cancer screening in Europe.
Zielonke N; Kregting LM; Heijnsdijk EAM; Veerus P; Heinävaara S; McKee M; de Kok IMCM; de Koning HJ; van Ravesteyn NT;
Int J Cancer; 2021 Jan; 148(2):406-418. PubMed ID: 32683673
[TBL] [Abstract][Full Text] [Related]
52. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe.
Guthmuller S; Carrieri V; Wübker A
J Health Econ; 2023 Dec; 92():102803. PubMed ID: 37688931
[TBL] [Abstract][Full Text] [Related]
53. Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data.
Hanley JA; Njor SH
Eur J Epidemiol; 2018 May; 33(5):465-472. PubMed ID: 29209939
[TBL] [Abstract][Full Text] [Related]
54. Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model.
Buckley E; Farshid G; Gill G; Kollias J; Koczwara B; Karapetis C; Adams J; Joshi R; Keefe D; Niyonsenga T; Powell K; Fusco K; Eckert M; Beckmann K; Roder D
Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 28271574
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer screening: evidence of benefit depends on the method used.
Autier P; Boniol M
BMC Med; 2012 Dec; 10():163. PubMed ID: 23234249
[TBL] [Abstract][Full Text] [Related]
56. Breast cancer screening case-control study design: impact on breast cancer mortality.
Paap E; Verbeek ALM; Puliti D; Paci E; Broeders MJM
Ann Oncol; 2011 Apr; 22(4):863-869. PubMed ID: 20924073
[TBL] [Abstract][Full Text] [Related]
57. Harms from breast cancer screening outweigh benefits if death caused by treatment is included.
Baum M
BMJ; 2013 Jan; 346():f385. PubMed ID: 23344314
[No Abstract] [Full Text] [Related]
58. [Breast cancer screening].
Hill C
Presse Med; 2014 May; 43(5):501-9. PubMed ID: 24703730
[TBL] [Abstract][Full Text] [Related]
59. A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.
Turnbull E; Priaulx J; van Ravesteyn NT; Heinävaara S; Siljander I; Senore C; Segnan N; Vokó Z; Hagymásy J; Jarm K; Veerus P; de Koning HJ; McKee M
Health Policy; 2018 Nov; 122(11):1198-1205. PubMed ID: 30195444
[TBL] [Abstract][Full Text] [Related]
60. Interpreting Breast Cancer Mortality Trends Related to Introduction of Mammography Screening: A Simulation Study.
Heggland T; Vatten LJ; Opdahl S; Weedon-Fekjær H
MDM Policy Pract; 2022; 7(2):23814683221131321. PubMed ID: 36225967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
